Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece

Inclusion criteria

• Healthy adult, female, 18 years of age or older with skin type I-IV;
• Having at least one suitable treatment area for hair removal with brown hair;
• Able and willing to comply with the treatment/follow-up schedule and requirements;
• Able to read, understand and provide written Informed Consent.
• Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to market preference test enrollment and throughout the course of the study treatment.

Exclusion criteria

• Showing symptoms of hormonal disorders, as per the Investigator's discretion;
• Use of oral isotretinoin (Accutane®) within 6 months
• Prior skin treatment with laser or other devices on the same treated areas prior to study enrollment or during the course of the study;
• History of keloid formation or poor wound healing in a previously injured skin area;
• Significant skin conditions affecting treated area or inflammatory skin conditions;
• Open laceration, abrasion, active cold sores or herpes sores on area to be treated;
• History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications;
• Having a history of bleeding disorder or taking anticoagulation medications before the washout period, per the package insert, and at the physician's discretion;
• Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the area to be treated, personal history of melanoma;
• Significant concurrent illness, such as diabetes, lupus, epilepsy or cardiac disorders, which might be aggravated as a result of treatment;
• Unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray or cream, during the course of the evaluation;
• Tattoos in the treatment areas;
• Dysplastic nevi in the treatment areas;
• Participation in a study of another device or drug within 3 month prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria;
• Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;
• Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study;
• Allergy or history of an allergy to any topical anesthetic used;
• Pregnant, expectation of pregnancy, postpartum (<3 months) or nursing (<6 weeks);
• History of livedo reticularis, an autoimmune vascular disease;
• Hypersensitivity at the treatment site to any agents, solutions, or gel used in the treatment (applies to ET handpiece only), if no alternative exists;